Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan pharmacokinetics in children with heart failure
NL-OMON37072Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of levosimendan in heart failure (HF), sponsored by Leiden University Medical Center. Primary endpoints: Pharmacokinetic profile of levosimendan and Pharmacokinetic profile of active metabolites. Started Dec 2012; status: active, not recruiting.
02
Drugs
levosimendan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NL-OMON37072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37072.